Effects of Mouthrinse on the Microbiome of the Oral Cavity and GI Tract
Part of paid clinical trials in Irvine, California.
- Sponsor
- University of California, Irvine
- Study ID
- NCT05603650
- Status
- Recruiting
Conditions
- Microbial Colonization
- Oral Bacterial Infection
- Oral Infection
- Viral Infection
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Accepted
Interventions
- Lumineux Oral Essentials rinse — OTHERmouthrinse
- Listerine rinse — OTHERmouthrinse
Study Details
The purpose of this research study is to identify the effects of 2 over-the-counter mouthwashes on bacteria and 3 viruses in the participant's mouth and gut. The participant will be randomly allocated to rinse their mouth twice daily either with Listerine mouthwash, Lumineux Oral Essentials mouthwash, or water. The overall duration of the study will be approximately 180 days and will include approximately 5 visits and 15-30 minutes for each visit with a total of approximately 2.5 hours of your time. Additionally, fecal matter will also be collected in some subjects using a commercial collection kit.
Key Dates
- Start date
- Sep 1, 2021
- Status verified
- Dec 2025
- Primary completion
- Dec 31, 2027
- Completion
- Dec 31, 2027
Study Design
- Enrollment
- 200 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- OTHER
Arms
- Placebo Comparator: Water rinserinse twice daily for 1 min with water
- Experimental: Lumineux Oral Essentials rinserinse twice daily for 1 min with Lumineux Oral Essentials rinse
- Experimental: Listerine rinserinse twice daily for 1 min with Listerine rinse
Primary Outcome Measure
total bacterial load and mRNA analysis [ Time Frame: Day 0 ]
Central Contacts
- Nicole Wakida, PhD949-824-4360
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Beckman Laser Institute and Medical Clinic | Irvine | California | 92612 | Petra Wilder-Smith, DDS, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Irvine, CA
By research site
Related Studies
- Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)PHASE1/PHASE2 · Recruiting · New York Medical College · San Francisco, California
- Donor-Derived Viral Specific T-cells (VSTs)PHASE1/PHASE2 · Recruiting · Children's Hospital Medical Center, Cincinnati · Akron, Ohio
- Third Party Viral Specific T-cells (VSTs)PHASE2 · Recruiting · Children's Hospital Medical Center, Cincinnati · Akron, Ohio
- Adoptive Cord Blood Immunotherapy for EBV, CMV, BKV and Adenovirus Reactivation/Infection or ProphylaxisPHASE1/PHASE2 · Recruiting · Catherine Bollard · Washington D.C., District of Columbia